Inside Innovation

Washington Research Foundation has awarded a $5.2 million, three-year BioInnovation Grant to launch a new clinical trials program between Fred Hutch Cancer Center and Seattle

The Allen Institute launched the Brain Knowledge Platform, an AI-powered research tool that integrates neuroscience data from multiple species, institutions, and disease areas. The platform,

UW’s Institute for Protein Design successfully used AI to create antibodies from scratch that bind precisely to their intended targets. These computer-designed molecules engaged real-world

Seattle-based Accipiter Biosciences has launched with $12.7 million in funding and partnerships with Pfizer and Kite Pharma to create AI-designed proteins capable of targeting multiple

OpenAI has entered a new collaboration with Lundbeck to expand the use of large language models in pharmaceutical research and drug development. Lundbeck, a global

AGC Biologics has partnered with Rarity PBC to develop and manufacture RDP-101, a gene therapy designed to treat adenosine deaminase severe combined immunodeficiency disorder (ADA-SCID),

In an interview with GEN, Nobel Laureate David Baker, PhD, director of the Institute for Protein Design at the University of Washington, reflected on the

Samsung has acquired Seattle-based digital health startup Xealth for approximately $115 million, marking a significant expansion of the tech giant’s push into digital healthcare. Founded

Pfizer and Astellas, in partnership with Merck & Co., reported that the antibody-drug Padcev and the immunotherapy Keytruda reduced the risk of death by 50

Seattle-area health technology startup Brook.ai has raised $28 million in Series B funding to expand its AI-driven remote care platform that helps patients manage chronic

Novo Nordisk has acquired rights to Omeros’ MASP-3 inhibitor zaltenibart, a rare-disease therapy, in a deal worth up to $2.1 billion, including $340 million in

Life Science Washington and Madrona hosted the AI Leadership Forum in Seattle to explore how artificial intelligence is transforming drug discovery, biomanufacturing, and healthcare. The